Navigating an Increasingly Complex Framework to Improve Outcomes for Patients Receiving Checkpoint Inhibitor–Based Therapy

Learn how multidisciplinary experts optimize outcomes and safety in patients receiving immune checkpoint inhibitor–based therapy with this focused MedicalMinute series of interactive presentations, along with downloadable slides and on-demand Webcast capturing a dynamic live Webinar. Then, access the free decision support tool to get individualized recommendations on managing immune-related adverse events based on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).

Interactive Decision Support Tool

Use this mobile-friendly interactive algorithm tool to receive National Comprehensive Cancer Network® (NCCN®) guidance on optimal management of immune-related adverse events associated with immune checkpoint inhibitor therapy, adapted from the NCCN Guidelines for Management of Immunotherapy-Related Toxicities v1.2020.

Released: April 21, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Produced in collaboration with
Supported by an educational grant from
Bristol-Myers Squibb
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.